Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glucose-insulin-potassium Therapy Improves Lactic Acidosis in Liver Transplantation

NCT03522181 is registered in ClinicalTrials.gov with Central South University as lead sponsor.

NCT NCT03522181
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03522181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glucose-insulin-potassium Therapy Improves Lactic Acidosis in Liver Transplantation
Lead sponsor
Central South University
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2016
Completion date
November 30, 2017
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplantation